Sotera Health Co. (SHC) Tops Q1 EPS by 3c; Offers FY22 Guidance
Sotera Health Co. (NASDAQ: SHC) reported Q1 EPS of $0.22, $0.03 better than the analyst estimate of $0.19. Revenue for the quarter came in at $237 million versus the consensus estimate of $230.07 million.
GUIDANCE:
Sotera Health Co. sees FY2022 EPS of $0.93-$0.99, versus the consensus of $0.95. Sotera Health Co. sees FY2022 revenue of $1-1.03 billion, versus the consensus of $1.01 billion.
For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.
